Innovation of health
Become the leading
go-to commercialisation platform
for innovative & cost-effective pharmaceuticals in Asia Pacific
Formiica’s Therapeutic Focus
Evolve to about 5 Therapeutic Areas addressing innovation and unmet needs
Oncology- Hematology
Solid Tumours
(Non-)Small Cell Lung Cancer
Breast Cancer
Rare Diseases
To be disclosed
Cardio-Metabolic
Chronic Kidney Disease
Heart Failure
Hypertension
Neurology
To be disclosed
Ophthalmology
Allergic Conjunctivitis
Post-Operative Ocular Inflammation
Immunology & Inflamation
Solid Tumours
(Non-)Small Cell Lung Cancer
the top in-license gateway
- Lunch innovative biologicals across Japan, South Korea, Australia and South East Asia
- Lead player in Japan, Australia, Korea and Southeast Asia (Thailand and Singapore) for innovative molecules as partner to go to for products in late-stage development
“Formiica is a unique one-stop market access platform that gives originators access to Asia Pacific markets”